107 related articles for article (PubMed ID: 2519031)
1. Gastric mucosal lesion in liver disease: impaired gastric mucosal defence mechanism in rats with induced liver injury and in patients with liver cirrhosis.
Tomoda J; Mizuno M; Sugihara T; Itano T; Tsuji T
J Gastroenterol Hepatol; 1989; 4 Suppl 1():136-9. PubMed ID: 2519031
[No Abstract] [Full Text] [Related]
2. Expression of a 72-kDa heat shock protein, and its cytoprotective function, in gastric mucosa in cirrhotic rats.
Watanabe D; Otaka M; Mikami K; Yoneyama K; Goto T; Miura K; Ohshima S; Lin JG; Shibuya T; Segawa D; Kataoka E; Konishi N; Odashima M; Sugawara M; Watanabe S
J Gastroenterol; 2004 Aug; 39(8):724-33. PubMed ID: 15338365
[TBL] [Abstract][Full Text] [Related]
3. [Portal hypertensive gastropathy].
Tao XH
Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):254-6. PubMed ID: 19403020
[No Abstract] [Full Text] [Related]
4. Zinc L-carnosine protects against mucosal injury in portal hypertensive gastropathy through induction of heat shock protein 72.
Mikami K; Otaka M; Watanabe D; Goto T; Endoh A; Miura K; Ohshima S; Yoneyama K; Sato M; Shibuya T; Segawa D; Kataoka E; Yoshino R; Takeuchi S; Sato W; Odashima M; Watanabe S
J Gastroenterol Hepatol; 2006 Nov; 21(11):1669-74. PubMed ID: 16984587
[TBL] [Abstract][Full Text] [Related]
5. [Gastrointestinal lesions in liver cirrhosis].
Fujiwara Y; Arakawa T; Higuchi K; Kuroki T
Nihon Rinsho; 1998 Sep; 56(9):2387-90. PubMed ID: 9780725
[TBL] [Abstract][Full Text] [Related]
6. Ablation of primary afferent neurons by neonatal capsaicin treatment reduces the susceptibility of the portal hypertensive gastric mucosa to ethanol-induced injury in cirrhotic rats.
Camara PR; Ferraz GJ; Franco-Penteado CF; Sbragia-Neto L; Meirelles LR; Teixeira SA; Muscara MN; Velloso LA; Antunes E; Ferraz JG
Eur J Pharmacol; 2008 Jul; 589(1-3):245-50. PubMed ID: 18555214
[TBL] [Abstract][Full Text] [Related]
7. The stomach in cirrhosis. The legend of Proteus retold.
Lingenfelser T; Krige JE
J Clin Gastroenterol; 1993 Sep; 17(2):92-6. PubMed ID: 8409328
[TBL] [Abstract][Full Text] [Related]
8. Causative relationship between a hyperdynamic state due to increased A-V anastomoses in the gastric wall and AGML in patients with liver cirrhosis.
Hasumi A; Aoki H; Shimazu M; Kawata S; Yoshimatsu Y
J Gastroenterol Hepatol; 1989; 4 Suppl 1():143-5. PubMed ID: 2519033
[No Abstract] [Full Text] [Related]
9. [Changes in mucosal and vascular bed in various parts of gastrointestinal tract in patients with liver cirrhosis with portal hypertension].
Sidorova IO
Eksp Klin Gastroenterol; 2012; (6):115-22. PubMed ID: 23402201
[No Abstract] [Full Text] [Related]
10. Role of injury of gastric parietal vessels by immunocomplexes in the mechanism of gastric mucosal lesion in portal hypertension with cirrhosis.
Mba Mba C; Yang Z
J Tongji Med Univ; 1997; 17(1):44-8. PubMed ID: 9639785
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of the gastric microcirculation.
Vigneri S; Scialabba A; Termini R; Germanà B; Vianello F; Grassi SA; Plebani M; Di Mario F
Ital J Gastroenterol; 1992 Jan; 24(1):22-30. PubMed ID: 1571576
[TBL] [Abstract][Full Text] [Related]
12. Underlying mechanism of portal hypertensive gastropathy in cirrhosis: a hemodynamic and morphological approach.
Curvêlo LA; Brabosa W; Rhor R; Lanzoni V; Parise ER; Ferrari AP; Kondo M
J Gastroenterol Hepatol; 2009 Sep; 24(9):1541-6. PubMed ID: 19743998
[TBL] [Abstract][Full Text] [Related]
13. The protective effect of vitamin E on gastric mucosal injury in rats with cirrhosis of the liver.
Cantürk NZ; Cantürk Z; Utkan NZ; Yenisey C; Ozbilim G; Gelen T; Yalman Y
Chin Med J (Engl); 1999 Jan; 112(1):56-60. PubMed ID: 11593643
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the incidence and significance of the "mosaic pattern" in patients with cirrhosis, noncirrhotic portal fibrosis, and extrahepatic obstruction.
Sarin SK; Misra SP; Singal A; Thorat V; Broor SL
Am J Gastroenterol; 1988 Nov; 83(11):1235-9. PubMed ID: 3263791
[TBL] [Abstract][Full Text] [Related]
15. Activity of gastric mucosal nitric oxide synthase in portal hypertensive gastropathy.
El-Newihi HM; Kanji VK; Mihas AA
Am J Gastroenterol; 1996 Mar; 91(3):535-8. PubMed ID: 8633504
[TBL] [Abstract][Full Text] [Related]
16. Toward a more realistic animal model for the study of portal hypertensive gastropathy.
Kotzampassi K; Eleftheriadis E
Am J Gastroenterol; 1994 Aug; 89(8):1272-3. PubMed ID: 8053458
[No Abstract] [Full Text] [Related]
17. Study of the relationship between portal hypertension and gastroduodenal mucosal lesions.
Mitani S; Yoshida J; Saitoh M; Asaka M; Matsushima T; Miyazaki T
J Gastroenterol Hepatol; 1989; 4 Suppl 1():146-50. PubMed ID: 2519034
[No Abstract] [Full Text] [Related]
18. Gastric mucosal blood flow in portal hypertension, gastropathy and sclerotherapy.
Triger DR; Walsh JT; Smart HL
J Gastroenterol Hepatol; 1989; 4 Suppl 1():94-5. PubMed ID: 2519099
[No Abstract] [Full Text] [Related]
19. Endoscopic, histologic and haemodynamic studies on portal hypertensive gastric mucosa.
Toyonaga A; Iwao T; Shimotsuura Y; Tanikawa K
J Gastroenterol Hepatol; 1989; 4 Suppl 1():132-5. PubMed ID: 2519030
[No Abstract] [Full Text] [Related]
20. [Portal hypertensive gastropathy].
Brinch K; Møller S; Henriksen JH; Becker PU
Ugeskr Laeger; 1995 Nov; 157(46):6421-5. PubMed ID: 7483098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
